-
RESTRICTED CONTRACT MARKETS FOR CME RULE 552 (“DUAL TRADING RESTRICTIONS”)
-
-
- To
- Members, Member Firms and Market Users
-
- From
- Market Regulation Department
-
- #
- SER-6000
-
- Notice Date
- 02 December 2011
-
- Effective Date
- 02 December 2011
-
CME Group has approved the following list of restricted markets for the implementation of CME Rule 552 (“Dual Trading Restrictions”), effective for the remainder of the fourth quarter of 2011 and the beginning of the first quarter of 2012.
• EURODOLLAR OPTIONS: Dual trading is restricted in the following contract month positions, up to but not including the last five business days of the contract month:
o First, second, third, fourth, fifth and sixth contract month position quarterly ED options.
o First and second position serial month ED options.
o First, second and third contract month position quarterly cycle One-Year ED MidCurve options.
o First and second position serial month One-Year ED MidCurve options.
• S&P 500® INDEX OPTIONS: Dual trading is restricted in the first quarterly contract month position S&P 500 options and the first serial contract month position S&P 500 options, up to but not including the last five business days of the contract month.
CME Group regularly reviews historical volume data in order to determine those contracts and contract months deemed mature and liquid pursuant to CME Rule 552. Any new restrictions on dual trading will occur only after prior notice has been provided to shareholder/members.
Please see the reverse side of this document for information on the date ranges during which dual trading is restricted in each of the restricted contract months.
EFFECTIVE DATES OF DUAL TRADING RESTRICTIONS ON CME PRODUCTS
The following schedule details the effective periods of the dual trading restrictions by contract month for CME products.
----DUAL TRADING RESTRICTION----
CME Product
Contract Month
Restricted Dates
Date Lifted
Termination of Trading Date
ED Options
Dec 2011
9/15/10
To
12/5/11
12/6/11
12/12/11
(Quarterlies)
Mar 2012
12/14/10
To
3/5/12
3/6/12
3/12/12
Jun 2012
3/15/11
To
6/4/12
6/5/12
6/11/12
Sep 2012
6/14/11
To
9/10/12
9/11/12
9/17/12
Dec 2012
9/20/11
To
12/10/12
12/11/12
12/17/12
Mar 2013
12/20/11
To
3/11/13
3/12/13
3/18/13
Jun 2013
3/20/12
To
6/10/13
6/11/13
6/17/13
ED Options
Jan 2012
10/17/11
To
1/6/12
1/9/12
1/13/12
(Serials)
Feb 2012
11/14/11
To
2/3/12
2/6/12
2/10/12
April 2012
1/16/12
To
4/6/12
4/9/12
4/13/12
1-Yr. MidCurve Options
(Quarterlies)
Dec 2011
6/20/11
To
12/9/11
12/12/11
12/16/11
Mar 2012
9/19/11
To
3/9/12
3/12/12
3/16/12
Jun 2012
12/19/11
To
6/8/12
6/11/12
6/15/12
Sep 2012
3/19/12
To
9/7/12
9/10/12
9/14/12
Dec 2012
6/18/12
To
12/7/12
12/10/12
12/14/12
1-Yr. MidCurve Options
(Serials)
Jan 2012
11/14/11
To
1/6/12
1/9/12
1/13/12
Feb 2012
1/16/12
To
2/3/12
2/6/12
2/10/12
April 2012
2/13/12
To
4/6/12
4/9/12
4/13/12
SP Options
Dec 2011
9/16/11
To
12/8/11
12/9/11
12/15/11
(Quarterlies)
Mar 2012
12/16/11
To
3/8/12
3/9/12
3/15/12
Jun 2012
3/16/12
To
6/7/12
6/8/12
6/14/12
Sep 2012
6/15/12
To
9/13/12
9/14/12
9/20/12
SP Options
Jan 2012
11/18/11
To
1/12/12
1/13/12
1/20/12
(Serials)
Feb 2012
1/20/12
To
2/9/12
2/10/12
2/17/12
April 2012
2/17/12
To
4/12/12
4/13/12
4/20/12
If you have any questions regarding the dual trading restrictions, please contact Shantell Stanberry, Senior Data Quality Analyst, Market Regulation, at 312.435.3642 or Lou Abarcar, Associate Director, Market Regulation, at 312.341.3236.
-
© 2024 CME Group Inc. All rights reserved.